Interoperable ecosystem for virtual care enabled wound management research
Active Definitive Contract Awarded Last action
- Contract number
- HT942524C0066
- Awardee
-
Solventum US LLC UEI NYZ3A8USQ3X9 Part of 3M Company
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $20,087,478
Award facts
- Opportunity
-
- DOD USAMRDC FY23-FY27 BROAD AGENCY ANNOUNCEMENT for Extramural Medical Research Department of Defense Dept. of the Army -- USAMRAA Special Notice · HT942523SBAA1 · Posted Sep 29, 2022
- Contract value 100% obligated
- $20,087,478.31 Current and potential, with all options
- Completion date 72% complete
- Current and potential, with all options
- Contracting staff
- Funding agency
- Medical Command Department of the Army, Department of Defense
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Basic Research
- Pricing
- Cost No Fee
- Place of performance
- St Paul, MN 55144, USA
- Legislative mandates
-
- Walsh-Healey Public Contracts Act FAR subpart 22.6
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $20,087,478 |
About this award
Solventum US LLC, a subsidiary of 3M Company, received a $20.1 million cost-no-fee definitive contract from the U.S. Army Medical Research and Development Command (USAMRDC) on September 6, 2024, to develop an "Interoperable Ecosystem for Virtual Care-Enabled Wound Management Research" project. The contract extends through September 5, 2027, and carries no small business set-aside designation, reflecting full and open competition. The award originated from a Defense Health Agency Broad Agency Announcement supporting USAMRDC's mission to advance medical solutions for service members and the general public through biomedical research. The contract location is Maplewood, Minnesota.
This research and development initiative aligns with USAMRDC's focus on applying advanced technology to military and civilian medical practice. Solventum's work in wound management research supports the Defense Health Agency's broader objectives to improve treatment protocols from point-of-injury through hospital settings, particularly for traumatic injuries affecting military personnel. The cost-no-fee structure indicates a partnership model where Solventum will manage performance within the ceiling value while foregoing profit-based fee arrangements, demonstrating the government's confidence in the contractor's technical capabilities and commitment to advancing wound care innovation for both defense and civilian healthcare applications.
Quick answers
Who was awarded contract HT942524C0066?
HT942524C0066 was awarded to Solventum US LLC by Defense Health Agency (Department of Defense) on September 6, 2024.
How much is contract HT942524C0066 worth?
The government has obligated $20,087,478 on HT942524C0066.
Which agency awarded contract HT942524C0066?
Defense Health Agency (Department of Defense) awarded HT942524C0066, with funding from Medical Command (Department of the Army).
Was contract HT942524C0066 competed?
The extent of competition for HT942524C0066 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award